Clinical Trials Browser

Phase 2 × Hematologic Diseases × Vancomycin × Clear all

NCT03030248 2020-09-10

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Phase 2 Completed

Clostridium Infections, Hematologic Diseases